Assessment of diastolic dysfunction in elderly hypertensive patients using integrated Doppler echocardiography

Blood Pressure

Volumn 18, Issue 3, 2009, Pages 135-141

  Dénes, Mónika ^a   Kiss, István ^b   Lengyel, Mária ^a  

^a Hungarian Institute of Cardiology   (Hungary)

^b Szent Imre Hospital   (Hungary)

Author keywords

Diastolic dysfunction; Hypertension; Tissue Doppler imaging

Indexed keywords

ADULT; AGED; ARTICLE; DECELERATION; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PRIORITY JOURNAL; PULMONARY VEIN; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; VEIN BLOOD FLOW; VELOCITY;

AGED; CARDIOMYOPATHIES; DIASTOLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; MALE; SYSTOLE;

EID: 70849086453     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050903013899     Document Type: Article

References (46)

1. Data from the Hungarian Central Statistical Offi ce.h ttp://www. ksh.hu/pls/ksh/docs/mdb/FE301/FE1A09-W/HU/180.
2. Liao D, C ooper L, C ai J, T oole JF, B ryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Stroke. 1996;27:2262-2270 .
3. Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens. 2000; 13(Suppl. 1):S3-S10.
4. 2007 Guidelines for the management of arterial hyp ertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536 .
5. Paulus WJ, T schöpe C, S anderson JE, R usconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007; 28: 2539-2550 .
6. Strand A, Kjeldsen SE, Gudmundsdottir H, Os I, S mith G, Bjornerheim R. Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years. Eur J Echocardiogr. 2008; 9: 34-39 .
7. Nagueh SF, A ppleton CP, G illebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22: 107-133.
8. Lengyel M, Nagy A, Zorandi A. Tissue Doppler echoc ardiography: a new technique to assess diastolic function. Orv Hetil. 2002; 143: 333-339 .
9. Lester SJ, T ajik J, N ishimura RA, O h JK, K handheria BK, Seward JB. Unllocking the mysteries of diastolic function. Deciphering the Rosetta stone 10 years later. J Am Coll Cardiol. 2008;51:679-689.
10. Redfi eld MM, Jacobsen SJ, B urnett JC Jr, M ahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289: 194-202 .
11. Abhayaratna WP, Marwick TH, S mith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart. 2006; 92: 1259-1264 .
12. Yamada H, G oh PP, Sun JP, O dabashian J, G arcia MJ, Thomas JD, Klein AL. Prevalence of left ventricular diastolic dysfunction by Doppler echocardiography: clinical application of the Canadian Consensus guidelines. J Am Soc Echocardiogr. 2002; 15: 1238-1244 .
13. Persson H, L onn E, E dner M, B aruch L, L ang CC, Morton JJ, et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence. Results from the CHARM echocardiographic substudy-CHARMES. J Am Coll Cardiol. 2007;49:687-694
14. Bella JN, P almieri V, Roman MJ, L iu JE, W elty TK, Lee ET, et al. Mitral ratio of peak early to late diastolic fi lling velocity as a predictor of mortality in middle-aged and elderly adults. The Strong Heart Study. Circulation. 2002; 15: 1238-1244 .
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. Recommendations for Chamber Quantifi cation: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifi cation Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463 .
16. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, et al. A new simplifi ed and accurate method for determinig ejection fraction with two-dimensional echocardiography. Circulation. 1981; 64: 744-752 .
17. Devereux RB, A lonso DR, L utas EM, G ottlieb GJ, C ampo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy fi ndings. Am J Cardiol. 1986; 57: 450-458 .
18. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age-and gender-related ventricular-vascular stiffening. A community-based study. Circulation. 2005;112:2254-2262.
19. Nagueh SF, M iddleton KJ, K opelen HA, Z oghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of fi lling pressures. J Am Coll Cardiol. 1997; 30: 1527-1533 .
20. Ommen SR, Nishimura RA, Appleton CP, M iller FA, Oh JK, Redfi eld MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular fi lling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788-1794 .
21. Almuntaser I, B rown A, Murphy R, C rean P, King G, Mahmud A, et al. Comparison of echocardiographic measures of left ventricular diastolic function in early hypertension. Am J Cardiol. 2007; 100: 1771-1775 .
22. Feigenbaum H. Enhanced echocardiographic techniques for imaging tissue. Am J Cardiol. 2000;86:25G-27G.
23. Nikitin NP, W itte KKA. Application of Tissue Doppler Imaging in Cardiology. Cardiology. 2004; 101: 170-184 .
24. Sohn DW, Chai IH, L ee DJ, K im HC, K im HS, O h BH, et al. Assessment of mitral annulus velocity by Doppler tissuemaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997; 30: 474-480 .
25. Bess RL, K han S, Rosman HS, C ohen GI, Allebban Z, Gardin JM, et al. Technical aspects of diastology: why mitral infl ow and tissue Doppler imaging are the preferred parameters? Echocardiography. 2006;23:332-339.
26. Wang M, Y ip GW, Wang AY, Zhang Y, H o PY, Tse MK, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens. 2005; 23: 132-139 .
27. Wang M, Y ip G, Yu CM, Z hang Q, Z hang Y, T se D, et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol. 2005; 45: 272-277 .
28. Dokainish H, Z oghbi WA, L akkis NM, Ambriz E, P atel R, Quinones MA, et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol. 2005; 45: 1223-1226 .
29. Tsang TS, Barnes ME, G ersh BJ, B ailey KR, S eward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002; 90: 1284-1289 .
30. Takemoto Y, Barnes ME, S eward JB, L ester SJ, A ppleton CA, Gersh BJ, et al. Usefulness of left atrial volume in predicting fi rst congestive heart failure in patients - 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005; 96: 832-836 .
31. Gerdts E, W achtell K, O mvik P, Otterstad JE, O ikarinen L, Boman K, Dahlof B, Devereux RB. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007; 49: 311-316 .
32. Emery WT, J adavji I, C hoy JB, L awrance RA. Investigating the European Society of Cardiology diastology guidelines in a practical scenario. Eur J Echocardiogr. 2008; 9: 685-691 .
33. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest. 2007; 117: 568-575 .
34. Qu P, D ing Y, X ia D, W ang H, T ian X. Variations in cardiac diastolic function in hypertensive patients with different left ventricular geometric patterns. Hypertens Res. 2001; 24: 601-604 .
35. Li L, S higematsu Y, H amada M, H iwada K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens Res. 2001; 24: 293-299
36. Muiesan ML, Salvetti M, Monteduro C, B onzi B, P aini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004; 43: 731-738 .
37. de Simone G, G ottdiener JS, C hinali M, M aurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: The Cardiovascular Health Study. Eur Heart J. 2008; 29: 741-747 .
38. Gerdts E, C ramariuc D, d e Simone G, Wachtell K, D alhöf B, Devereux RB. Impact on left ventricular geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008; 9: 809-815 .
39. Farsang C, L engyel M, B orbás S, Z orándi A, Dienes BS; VERITAS Investigators. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hyper tension (VERITAS). Curr Res Med Opin. 2003; 19: 205-227 .
40. Pavlopoulos H, Grapsa J, Stefanadi E, Kamperidis V, P hilippou E, Dawson D, et al. The evolution of diastolic dysfunction in the hypertensive disease. Eur J Echocardiogr. 2008; 9: 772-778 .
41. Dahlöf B. Regression of left ventricular hypertrophy -Are there differences between antihypertensive agents? Cardiology. 1992;81:307-315.
42. Schieder RE, M arkus P, K lingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA. 1996;275:1507-1513.
43. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007; 369: 2079-2087 .
44. Devereux RB, P almieri V, Sharpe N, D e Quattro V, Bella JN, de Simone G, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic fi lling in hypertension. The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) Trial. Circulation. 2001;104: 1248-1254.
45. Dzau V, Braunwald E and Participants. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991; 121: 1244-1262 .
46. Denes M, Lengyel M. Normal aging and diastolic function. Eur J Echocardiogr. 2007;8:S49.